Article
Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications.
Pharmacology & therapeutics - 1 Sept 2006
Tao Ya-Xiong
Abstract excerpt
Since the discovery of the first rhodopsin mutation that causes retinitis pigmentosa in 1990, significant progresses have been made in elucidating the pathophysiology of diseases caused by inactivating mutations of G protein-coupled receptors (GPCRs). This review aims to compile the compelling evidence accumulated during the past 15 years demonstrating the etiologies of more than a dozen diseases caused by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
